SUGEN

Sugen is a biotechnology company that specializes in target-driven drug discovery and development for novel development-stage cancer therapies. It develops new therapeutic approaches to various diseases through its development of small molecule inhibitors that regulate particular signaling pathways. Sugen owns three anti-cancer drugs in clinical development, including novel cytostatic agents and angiogenesis inhibitors. In addition to its current focus in oncology, Sugen is applying its technology platform to identify and validate novel targets for a range of potential clinical applications.
Similar Organizations
AEBi - Accelerated Evolution Biotechnologies
AEBi is engaged in the discovery and development of therapeutic peptides.
Athna Biotech
Athna Biotech specializes in developing novel nanotherapeutics for cancer.
Fustibal
Fustibal is a biotechnology startup that develops antibody-based nanomedicines for multi-targeted cancer therapy.
READDI
READDI is retooling the drug discovery and development process to rapidly develop new antiviral drug solutions for the future.
Techaldo
Techaldo specializes in research and development of technologies for growing high-yielding and healthy food for human beings.
Founder
Investors List
Venrock
Venrock investment in Pre Seed Round - Sugen
More informations about "Sugen"
Sugen - Crunchbase Company Profile & Funding
Sugen is a biotechnology company that specializes in target-driven drug discovery and development for novel development-stage cancer therapies. It โฆSee details»
Sugen falls as casualty of PfizerโPharmacia merger
Jul 1, 2003 Sugen laid the groundwork for future kinase work with its Human Kinome project, the cataloging of all 518 human protein kinases (Science 298, โฆSee details»
SUGEN 2025 Company Profile: Valuation, Investors, Acquisition
SUGEN General Information Description. Developer of drugs and therapeutics involving kinases and phosphatases. The company develops drugs to target signal transduction pathways inside โฆSee details»
SUGEN - AFSUG
May 7, 2020 With a mission to provide a powerful, international voice, SUGEN unites regional SAP User Groups in an open, honest dialogue between members and SAP. The SAP user group executive network (SUGEN) includes leaders โฆSee details»
Sugen Life - Permitted Daily Exposure Limit โฆ
Sugen Life Sciences (SLS) is a Contract Research Organization with key focus on Pre-Clinical safety, Efficacy, Toxicology, and Clinical research services to biopharma industries and research organizations. All studies are conducted in โฆSee details»
SUGEN - Early History and Focus | Early History Focus - LiquiSearch
Sugen was founded in 1991 in Redwood City, California, by veteran biotech investor Stephen Evans-Freke and kinase researchers Joseph Schlessinger and Axel Ullrich. The name was โฆSee details»
Research Retreat: Pfizer Eliminates Sugen, Shrinks Cancer ...
Jul 16, 2003 Now Sugen, based in South San Francisco, will vanish completely, a casualty of the $57 billion Pfizer-Pharmacia merger, completed April 16. โMost of the employees will sort โฆSee details»
Sugen - Funding, Financials, Valuation & Investors - Crunchbase
Jan 1, 1991 Sugen specializes in target-driven drug discovery and development for novel development-stage cancer therapies. ... Experience the new Crunchbase, powered by AI . โฆSee details»
sugen life โ Medium
Mar 26, 2021 Read writing from sugen life on Medium. SLS is a Contract Research Organization with a key focus on Pre-Clinical safety, Efficacy, Toxicology, and Clinical research services to โฆSee details»
Occupational Exposure Limit Determinations | Training โฆ
Sugen Life Sciences (SLS) is a Contract Research Organization with key focus on Pre-Clinical safety, Efficacy, Toxicology, and Clinical research services to biopharma industries and research organizations. All studies are conducted in โฆSee details»
Series 1 Episode 1: SUGEN - The Importance to SAP Users
Series 1 Episode 1: SUGEN - The Importance to SAP Users. Our guests discuss the value User Groups and the global network of SUGEN (SAP User Group Executive Network) provide both โฆSee details»
SUGEN - SAP User Group Executive Network | LinkedIn
SUGEN - SAP User Group Executive Network | 312 followers on LinkedIn. SUGEN provides a powerful, international voice for an open, honest dialogue between all national user groups โฆSee details»
Senate confirms Johns Hopkins surgeon Marty Makary to lead โฆ
11 hours ago Despite the uncertainty currently sweeping through the Food and Drug Administration, President Donald Trumpโs pick to lead the U.S. | Late Tuesday, the Senate โฆSee details»
SAP User Group Executive Network (SUGEN) | UKISUG
The SAP User Group Executive Network (SUGEN) consists of autonomous, non-profit organisations that support the exchange of ideas and information, the education of its โฆSee details»
Quโest-ce que le SUGEN - Signe
Le SUGEN a une voix forte au niveau international et encourage un dialogue ouvert et honnête entre ses membres et SAP, inégalé dans lโindustrie de la fabrication de logiciels. SUGEN โฆSee details»
The American College of Surgeons | ACS
Mar 5, 2025 The American College of Surgeons is dedicated to improving the care of the surgical patient and to safeguarding standards of care in an optimal and ethical practice โฆSee details»
SUGEN - SAP User Group Executive Network | LinkedIn
SUGEN - SAP User Group Executive Network | 274 followers on LinkedIn. SUGEN provides a powerful, international voice for an open, honest dialogue between all national user groups โฆSee details»
AUSAPE | SUGEN- Noviembre 24
El encuentro SUGEN F2F de la red internacional de grupos de usuarios de SAP es uno de los eventos más relevantes de la comunidad SAP a nivel internacional, y como en cada edición, โฆSee details»
ASA: American Surgical Association
The American Surgical Association was founded in 1880 and is the nation's oldest and most prestigious surgical organization. Its members include the nations most prominent surgeons โฆSee details»
SUGEN - SAP User Group Executive Network | LinkedIn
SUGEN - SAP User Group Executive Network | 325 följare på LinkedIn. SUGEN provides a powerful, international voice for an open, honest dialogue between all national user groups โฆSee details»